BLUEPRINT MEDICINES CORP (BPMC)
US09627Y1091 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 89.36M | 71.29M | 119.70M | 209.90M | 684.60M | |||
| Marketable Securities | 644.82M | 639.36M | 825.30M | 267.20M | 187.20M | |||
| Receivables | 65.81M | 43.18M | 36.90M | 37.00M | 25.30M | |||
| Inventories | 12.53M | 21.22M | 29.70M | 21.80M | 8.60M | |||
| Other Current Assets | 42.33M | 33.35M | 35.00M | 18.10M | 22.00M | |||
| Total Current Assets | 854.85M | 808.39M | 1.05B | 554.00M | 927.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 104.27M | 115.65M | 115.20M | 120.90M | 101.70M | |||
| Investments And Advances | 148.18M | 56.53M | 133.50M | 557.50M | 677.90M | |||
| Other Non-Current Assets | 92.36M | 68.68M | 54.60M | 19.80M | 11.10M | |||
| Total Non-Current Assets | 344.80M | 240.86M | 303.20M | 698.20M | 790.60M | |||
| TOTAL ASSETS | 1.20B | 1.05B | 1.35B | 1.25B | 1.72B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 45.03M | 30.28M | 16.90M | N/A | N/A | |||
| Accrued Expenses | 143.89M | 139.93M | 141.70M | 129.90M | 113.90M | |||
| Accounts Payable | 4.72M | 4.71M | 2.70M | 8.30M | 4.40M | |||
| Other Current Liabilities | 64.02M | 40.01M | 22.00M | 11.50M | 12.60M | |||
| Total Current Liabilities | 257.66M | 214.92M | 183.20M | 149.80M | 130.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 341.54M | 208.53M | 122.20M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 287.30M | 495.18M | 529.80M | 131.70M | 117.50M | |||
| Total Non-Current Liabilities | 628.84M | 703.72M | 652.00M | 131.70M | 117.50M | |||
| TOTAL LIABILITIES | 886.50M | 918.64M | 835.20M | 281.50M | 248.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -2.36B | -2.34B | -1.83B | -1.28B | -631.40M | |||
| Additional Paid In Capital | 2.67B | 2.47B | 2.36B | 2.25B | 2.11B | |||
| Common Shares | 63.00K | 61.00K | 100.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | -1.07M | -3.50M | -10.40M | -4.10M | -5.20M | |||
| Shares Outstanding | 63.45M | 61.15M | 60.00M | 59.10M | 57.80M | |||
| Tangible Book Value per Share | 4.93 | 2.14 | 8.58 | 16.42 | 25.43 | |||
| Total Shareholders' Equity | 313.15M | 130.61M | 514.70M | 970.70M | 1.47B | |||
| TOTAL LIABILITIES AND EQUITY | 1.20B | 1.05B | 1.35B | 1.25B | 1.72B | |||
| Statistics | ||||||||
| Debt/Equity | 1.09 | 1.60 | 0.24 | N/A | N/A | |||
| Current Ratio | 3.32 | 3.76 | 5.71 | 3.70 | 7.09 | |||
| Return On Assets (ROA) | -10.67% | -48.32% | -41.30% | -51.44% | 18.27% | |||
| Return On Equity (ROE) | -40.89% | -388.17% | -108.32% | -66.35% | 21.35% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | 15.36% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | 34.07% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | N/A | 34.07% | |||
All data in USD , ROIC based on taxRate of 0.21